levodopa 42 MG Inhalation Powder Capsule

RxCUI: 2107616
RxNorm name: levodopa 42 MG Inhalation Powder Capsule
Display name: levodopa 42 MG Inhalation Powder Capsule
Full name: levodopa 42 MG Inhalation Powder Capsule
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:14

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Inbrija	LEVODOPA	Merz Pharmaceuticals, LLC	077c0f39-a3a2-4b2b-a184-09131889dcfb	2026-07-20	Warnings, Adverse reactions	Exact identifier rxcui: 2107616
Inbrija	LEVODOPA	Merz Pharmaceuticals, LLC	a906f8e1-6e1c-480a-8276-c01bc65dd3be	2026-01-16	Warnings, Adverse reactions	Exact identifier rxcui: 2107616

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
a906f8e1-6e1c-480a-8276-c01bc65dd3be	levodopa 42 MG Inhalation Powder Capsule [PSN] · levodopa 42 MG Inhalation Powder [SCD] · L-DOPA 42 MG Inhalation Powder [SY]	3	13	These highlights do not include all the information needed to use INBRIJA safely and effectively. See full prescribing information for INBRIJA. INBRIJA ® (levodopa inhalation powder), for oral inhalation use Initial U.S. Approval: 1970	20260116
077c0f39-a3a2-4b2b-a184-09131889dcfb	levodopa 42 MG Inhalation Powder Capsule [PSN] · levodopa 42 MG Inhalation Powder [SCD] · L-DOPA 42 MG Inhalation Powder [SY]	3	1	These highlights do not include all the information needed to use INBRIJA safely and effectively. See full prescribing information for INBRIJA. INBRIJA ® (levodopa inhalation powder), for oral inhalation use Initial U.S. Approval: 1970	20250922